Idiopathic Intracranial Hypertension

Posted on by Dr Shibal Bhartiya

What is idiopathic intracranial hypertension?

Idiopathic intracranial hypertension, or IIH, is the result of an increased pressure within the spaces that surround the brain and spinal cord. Normally, the cerebrospinal fluid (CSF) fills up this space. The CSF is responsible for protecting the brain from trauma, and provide it with nutrition. In addition, it also removes the toxins and waste.

What causes idiopathic intracranial hypertension?

Intracranial hypertension can be either acute or chronic, depending upon how long the disease has lingered.

Typically, in chronic or longstanding IIH, the increased pressure may cause a swelling of the optic nerve. This swelling of the optic nerve is called papilledema.

Chronic increase in CSF pressure may be a result of:

  • Brain tumor
  • Blood clot in the brain
  • Excessive intake of vitamin A
  • Use of tetracycline
  • Most commonly, without a specific reason

When there is no detectable cause for the increased CSF pressure, the condition is known as idiopathic intracranial hypertension.

What are the symptoms of idiopathic intracranial hypertension?

Very often, the symptoms of IIH are non specific. The most common symptoms include:

  • Headaches
  • Vision loss
  • Poor peripheral vision
  • Double vision
  • Squint or deviation of eyes
  • Transient episodes of blindness
  • In addition, some patients report a ringing in the ears and pain in the neck and shoulders.

In fact, the symptoms of IIH often mimic those of a brain tumor. Therefore, the disease is often called pseudotumor cerebri, or “false brain tumor.”

Are you at risk for IIH?

Surprisingly, IIH is most common in women between the ages of 20 and 50; more than 90% of those affected are women.

Remember, high body weight or obesity, defined as a body mass index (BMI) greater than 30, is a major risk factor. Your risk also increases if you’ve recently gained a lot of weight.

How is Idiopathic intracranial hypertension diagnosed?

Usually, your neurologist will take a thorough medical history and perform a physical exam.

Thereafter, your eye doctor will look for signs of increased intracranial pressure on the eye. These include:

  • Papilledema
  • Visual loss
  • Possible weakness in the lateral rectus muscles, which may lead to a squint, and possible double vision.

What are the tests for Idiopathic intracranial hypertension?

The eye tests performed are:

Other tests include:

  • Brain imaging, including computed tomography (CT) and magnetic resonance imaging (MRI) scans
  • Lumbar puncture, or spinal tap, to measure CSF pressure, and to test it for infection.

in fact, all these tests. may be required for diagnosis, and have to be repeated at regular intervals to monitor the clinical course of the disease.

How is idiopathic intracranial hypertension treated?

Acetazolamide is the most commonly used drug that decreases CSF production. Therefore, it decreases the intracranial pressure.  

In addition, weight loss through healthy eating, restriction of salt intake, and exercise is key to the treatment of IIH.

Rarely, surgery may be required to relieve pressure on the optic nerve.

This page is part of the Neuro-Ophthalmology hub. Read about our full approach to neurological vision conditions. Some vision problems are not eye problems. They are brain problems, nerve problems, or vascular problems, that show up in the eye first. Also read about optic nerve disease,  raised intracranial pressure, Vision not clear but tests normal, double vision, and conditions where no diagnosis has yet been reached.

About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google